Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|EGFR-vIII CAR-T Cells||EGFR-vIII CAR-T cells are T-cells that have been modified to express a chimeric antigen receptor (CAR) that targets EGFR variant III (EGFR-vIII), potentially leading to decreased growth of EGFR-vIII-expresing tumors (PMID: 28649003).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|
|NCT03283631||Phase I||EGFR-vIII CAR-T Cells||Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM||Suspended|